Bio-UV Group SA (FR:ALTUV)
:ALTUV
Want to see FR:ALTUV full AI Analyst Report?
ALTUV Stock Chart & Stats
€1.58
-€0.01(-0.43%)
At close: 4:00 PM EST
€1.58
-€0.01(-0.43%)
Day’s Range― - ―
52-Week Range€1.22 - €2.12
Previous CloseN/A
Volume4.70K
Average Volume (3M)11.56K
Market Cap
€19.09M
Enterprise Value€30.67M
Total Cash (Recent Filing)€10.18M
Total Debt (Recent Filing)€20.23M
Price to Earnings (P/E)21.8
Beta0.35
Next Earnings
Sep 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding14,154,679
10 Day Avg. Volume12,225
30 Day Avg. Volume11,557
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.52
Price to Sales (P/S)0.58
P/FCF Ratio6.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.07
Revenue Forecast (FY)€38.50M
Bulls Say, Bears Say
Bulls Say
Cash GenerationConsistent positive operating cash flow and accelerating free cash flow in 2025 improve financial flexibility. Durable cash conversion supports reinvestment in product development, funds working capital for project execution, and reduces dependence on external financing during cyclical revenue periods.
Balance-sheet ResilienceManageable leverage with debt below equity and strengthened equity in 2025 provides a buffer against shocks and lowers refinancing risk. A healthier balance sheet supports bidding for larger projects, absorbing temporary earnings volatility, and funding modest organic growth without heavy external capital.
After-sales Recurring RevenueA business mix that includes maintenance, spares and service contracts creates recurring revenue streams that smooth cycles from lumpier system sales. Durable aftermarket income enhances lifetime customer value, aids margin stability, and supports predictable cash flows for 2–6+ month planning horizons.
Bears Say
Declining Revenue TrendSustained revenue declines from 2023–2025 limit operating leverage and constrain the company's ability to scale fixed-cost investments. Lower top-line pressure reduces margin expansion potential, weakens negotiating power with suppliers, and makes consistent earnings recovery harder without market share gains.
Profitability VolatilityWide swings in gross profit and compressed margins point to inconsistent cost control or pricing power across projects. This earnings volatility undermines predictability of cash generation and hampers the firm's ability to compound returns, increasing execution risk for long-term investors and lenders.
Low Returns / Limited ScalePersistently low ROE driven by thin net income suggests the company struggles to convert assets into profitable growth. Modest scale and limited margin headroom reduce competitive flexibility, making it harder to absorb price pressure or invest for market share without diluting returns.
Bio-UV Group SA News
ALTUV FAQ
What was Bio-UV Group SA’s price range in the past 12 months?
Bio-UV Group SA lowest stock price was €1.22 and its highest was €2.12 in the past 12 months.
What is Bio-UV Group SA’s market cap?
Bio-UV Group SA’s market cap is €19.09M.
When is Bio-UV Group SA’s upcoming earnings report date?
Bio-UV Group SA’s upcoming earnings report date is Sep 23, 2026 which is in 108 days.
How were Bio-UV Group SA’s earnings last quarter?
Bio-UV Group SA released its earnings results on Apr 08, 2026. The company reported -€0.037 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.037.
Is Bio-UV Group SA overvalued?
According to Wall Street analysts Bio-UV Group SA’s price is currently Overvalued.
Does Bio-UV Group SA pay dividends?
Bio-UV Group SA pays a Annually dividend of €0.06 which represents an annual dividend yield of N/A. See more information on Bio-UV Group SA dividends here
What is Bio-UV Group SA’s EPS estimate?
Bio-UV Group SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bio-UV Group SA have?
Bio-UV Group SA has 14,154,679 shares outstanding.
What happened to Bio-UV Group SA’s price movement after its last earnings report?
Bio-UV Group SA reported an EPS of -€0.037 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.462%.
Which hedge fund is a major shareholder of Bio-UV Group SA?
Currently, no hedge funds are holding shares in FR:ALTUV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bio-UV Group SA
Bio-UV Group SA (ALTUV) specializes in the design and manufacturing of advanced disinfection systems utilizing ultraviolet (UV) technology. Operating primarily in the water treatment and sanitation sectors, the company offers a range of products that cater to various applications, including swimming pools, aquaculture, drinking water, and industrial processes. Bio-UV Group is committed to providing eco-friendly solutions that enhance water quality while minimizing environmental impact.
Technical Analysis
Derichebourg
―
Seche Environnement
―
Veolia Environnement
―
Orege SA
―
Groupe Pizzorno Environnement SA
―